Jump Financial, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.83 - $3.02 $19,568 - $32,292	-10,693 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$2.88 - $4.3 $8,389 - $12,525	-2,913 Reduced 21.41%	10,693 $31,000
Q3 2021 Nov 12, 2021	BUY	$3.72 - $5.35 $2,563 - $3,686	689 Added 5.33%	13,606 $58,000
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.98 $49,472 - $77,243	12,917 New	12,917 $68,000
Q4 2020 Feb 12, 2021	SELL	$3.27 - $4.64 $40,875 - $57,999	-12,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.23 - $4.3 $40,375 - $53,750	12,500 New	12,500 $41,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.